The Untimely Reporting of Drug-Resistant Outbreaks in the United States

  21 March 2020

The unconscionable delay and coverup of the novel coronavirus by China’s government has spurred worldwide condemnation.  For almost a month after the outbreak was suspected,(1) the information was hidden from their citizens which inflamed public unrest and mistrust in their government. (2)  An outcome that no major world power should desire.

Unfortunately, it appears that public reporting of COVID-19 cases by the Chinese government is more timely compared to what the average citizens in the United States are experiencing regarding drug-resistant bacteria.  The US Centers for Disease Control and Prevention (CDC) estimates at a minimum, that these pathogens cause 47,800 deaths each year(3).  According to Michael Craig, MPP, at the CDC, “Every 11 seconds someone in the United States gets a resistant infection and someone dies every 15 minutes.”(4)  However, only a few of these infections are publicly reported and when they are, the delayed reports do far too little to safeguard the public.

Further reading: CDDEP
Author(s): Kevin Kavanagh
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!